HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,411,000 | -78.6% | 3,000,000 | -81.2% | 0.31% | -87.7% |
| Q4 2018 | $15,929,000 | -1.0% | 16,000,000 | 0.0% | 2.50% | +65.7% |
| Q3 2018 | $16,094,000 | +5.1% | 16,000,000 | 0.0% | 1.51% | +9.7% |
| Q2 2018 | $15,312,000 | +4.4% | 16,000,000 | 0.0% | 1.38% | +2.2% |
| Q1 2018 | $14,672,000 | -1.4% | 16,000,000 | 0.0% | 1.35% | +4.5% |
| Q4 2017 | $14,880,000 | +3.0% | 16,000,000 | 0.0% | 1.29% | -12.0% |
| Q3 2017 | $14,450,000 | +4.8% | 16,000,000 | 0.0% | 1.47% | -23.4% |
| Q2 2017 | $13,790,000 | -5.3% | 16,000,000 | 0.0% | 1.91% | -10.1% |
| Q1 2017 | $14,560,000 | -60.8% | 16,000,000 | -59.0% | 2.13% | -76.4% |
| Q4 2016 | $37,098,000 | +1.0% | 39,000,000 | +2.6% | 9.02% | +86.7% |
| Q3 2016 | $36,741,000 | +1927.6% | 38,000,000 | +1800.0% | 4.83% | +903.7% |
| Q2 2016 | $1,812,000 | – | 2,000,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|